Literature DB >> 11196713

Is interleukin-6 important in inflammatory bowel disease?

K Koss1, J Satsangi, K I Welsh, D P Jewell.   

Abstract

The IL-6 gene maps to an area of chromosome 7 known to be significant for susceptibility to inflammatory bowel disease. The functional effects of interleukin-6 (IL-6) polymorphisms in the 4th intron and in the 3' flanking region of IL-6 gene were studied in 192 inflammatory bowel disease patients and healthy subjects. A polymerase chain reaction with sequence-specific primers (PCR-SSP) was used to determine a G to A polymorphism (* at position 4470 in intron 4 of IL-6 gene). Four alleles in the 3' flanking region were studied using a variable number of tandem repeats PCR (VNTR-PCR) amplification. Production of IL-6 was measured in lipopolysaccharide (LPS) stimulated whole blood samples by an enzyme-linked immunosorbent assay (ELISA). A modest increase in the frequency of the IL-6*G allele was noted in Crohn's disease (CD) patients (50%) and ulcerative colitis (UC) patients (46.1%) as compared to controls (39.8%, P = 0.025). We were unable to find any significant functional effect of the IL-6 polymorphisms tested on IL-6 protein production. We postulate that the IL-6 polymorphisms investigated here may be in linkage disequilibrium with a susceptibility gene and that they may be utilised as genetic markers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196713     DOI: 10.1038/sj.gene.6363658

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  5 in total

1.  Differential regulation of TLR4 expression in human B cells and monocytes.

Authors:  Lisa M Ganley-Leal; YanMei Liang; Madhumita Jagannathan-Bogdan; Francis A Farraye; Barbara S Nikolajczyk
Journal:  Mol Immunol       Date:  2010-10-16       Impact factor: 4.407

Review 2.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.

Authors:  Mark M T J Broekman; Hennie M J Roelofs; Frank Hoentjen; Renske Wiegertjes; Nicole Stoel; Leo A Joosten; Dirk J de Jong; Geert J A Wanten
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 4.  STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?

Authors:  Paul M Nguyen; Tracy L Putoczki; Matthias Ernst
Journal:  J Interferon Cytokine Res       Date:  2015-03-11       Impact factor: 2.607

5.  Utilization of physiologically-based pharmacokinetic model to assess disease-mediated therapeutic protein-disease-drug interaction in immune-mediated inflammatory diseases.

Authors:  Lujing Wang; Yang Chen; Wangda Zhou; Xin Miao; Honghui Zhou
Journal:  Clin Transl Sci       Date:  2021-10-20       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.